Collectively, these markers CD73+ and CD90+/CD105+ promote tumor growth, angiogenesis, and metastasis in breast cancer cells, and positive expression of these markers in PDOs was an indicator of the MSC phenotype of the original tumor. The gene discussed is THY1; the disease is breast carcinoma.